Community pharmacies in England are preparing to offer treatment for five additional conditions through an expanded Pharmacy First service this autumn. The change is intended to let more people get assessment and treatment without first booking a GP appointment, while making greater use of independent-prescribing pharmacists.
NHS England announced in September that the new prescribing pathways will cover migraine, mild to moderate acne, scabies and mild skin or soft-tissue infections, acute otitis externa in adults, and seasonal allergic rhinitis in children aged 4 to 11. The NHS England announcement says participating pharmacies will be able to assess eligible patients and provide treatment for these conditions without a GP appointment first.
Community Pharmacy England has also confirmed the five pathways and published implementation information for pharmacy owners. Its prescribing guidance was updated again on 25 September 2026 as the autumn rollout approached.
What is changing?
Pharmacy First already allows community pharmacies to assess and treat a number of common conditions through nationally defined pathways. The new change extends the model further by using pharmacist independent prescribers.
The five new prescribing-only pathways are:
- acute otitis externa for adults aged 18 and over;
- seasonal allergic rhinitis for children aged 4 to 11;
- mild to moderate acne for young people;
- low-frequency episodic migraine for adults aged 18 to 64; and
- mild skin and soft-tissue infections and scabies.
That does not mean every pharmacy will offer every pathway immediately. Participation depends on local rollout, trained prescribers and the service arrangements in place at an individual pharmacy.
Why this matters for patients
The practical attraction is convenience. For certain common conditions, a person may be able to walk into a participating pharmacy, be assessed and receive treatment without waiting for a routine GP appointment.
That can be particularly useful when symptoms are uncomfortable but not obviously severe enough for urgent care. It may also help people who find it difficult to attend GP appointments during working hours.
But “quicker” should not be confused with “simpler diagnosis.” Migraine, skin problems, ear symptoms and allergic symptoms can sometimes resemble more serious conditions. Pharmacists will use clinical pathways and referral criteria, and some people will still need to be directed to a GP, urgent treatment centre, emergency department or another service.
What happens during a Pharmacy First consultation?
A pharmacist will usually ask about symptoms, how long they have been present, relevant medical conditions, current medicines, allergies and any warning signs. Depending on the problem, they may examine the affected area or carry out an appropriate clinical assessment.
If the person meets the pathway criteria, the pharmacist may be able to recommend or prescribe treatment. If the presentation falls outside the pathway, or if there are red flags, the pharmacist should direct the patient to a more appropriate service.
That is why it helps to bring accurate information. If you take regular medicines, know their names and doses. Tell the pharmacist about allergies, pregnancy, breastfeeding, significant medical conditions and recent treatment.
Our Healthcare Navigation guide explains how to prepare a concise medication and symptom summary before speaking to a health professional.
Migraine: what the new pathway means
The new migraine pathway is for low-frequency episodic migraine in adults aged 18 to 64. That wording matters. It does not mean pharmacies will manage every severe headache or every person with recurrent neurological symptoms.
A first severe headache, a sudden “worst ever” headache, headache after a significant injury, headache with new weakness or speech problems, fever with neck stiffness, or other concerning neurological symptoms may require urgent medical assessment rather than a routine pharmacy consultation.
For people with an established pattern of uncomplicated episodic migraine, however, an appropriately trained pharmacist may be able to assess symptoms and prescribe within the new pathway.
Acne: useful, but not every case belongs in pharmacy
Mild to moderate acne can have a significant effect on confidence and quality of life, especially for teenagers and young adults. Easier access to appropriate treatment may reduce the period people spend trying ineffective over-the-counter products.
More severe acne, painful nodules, significant scarring, or symptoms associated with substantial emotional distress may need GP or specialist review. Acne can also be affected by medicines and hormonal conditions, so a pharmacist may refer onward when the presentation does not fit the pathway.
Scabies and skin infections
Scabies spreads through close skin contact and can affect entire households. A pharmacy pathway may improve access to treatment and advice, but successful management often depends on treating close contacts appropriately and following instructions about clothing and bedding.
Skin and soft-tissue infections also vary greatly in severity. A small localised infection may fit a pharmacy pathway, while rapidly spreading redness, severe pain, fever, systemic illness or infection near certain vulnerable areas may need urgent medical assessment.
Ear infections and rhinitis
The acute otitis externa pathway applies to adults aged 18 and over. Symptoms can include ear pain, irritation, discharge or discomfort around the ear canal. People with severe symptoms, significant swelling, systemic illness, diabetes, immune suppression or possible complications may need assessment outside the pharmacy pathway.
For seasonal allergic rhinitis, the new pathway targets children aged 4 to 11. This may be helpful for families managing predictable pollen-related symptoms, but persistent breathing difficulty, wheezing, severe facial swelling or symptoms suggesting another condition need appropriate medical assessment.
Will every pharmacist be able to prescribe?
No. The expansion depends on pharmacist independent prescribers and participating pharmacies. Pharmacy teams will also be working within nationally defined service requirements.
That means patients should not assume that every local pharmacy can provide the new service on day one. It is sensible to check availability, especially if travelling specifically for a consultation.
Does this replace the GP?
No. Pharmacy First is designed to give patients another appropriate route into care for selected conditions. GPs remain essential for complex symptoms, long-term conditions, diagnostic uncertainty, ongoing monitoring and situations that fall outside pharmacy pathways.
The useful change is that a GP appointment may no longer be the only first step for some common problems. That can free GP capacity while giving patients quicker access to treatment where a pharmacy consultation is clinically suitable.
What should patients do before choosing where to go?
Think about severity, duration and warning signs. If symptoms are mild and match one of the Pharmacy First conditions, a participating pharmacy may be a sensible first contact. If symptoms are severe, rapidly worsening, unusual, or accompanied by significant systemic illness, another service may be more appropriate.
NHS 111 can help when you are unsure where to seek care. For life-threatening symptoms, call 999.
Why the autumn rollout is worth watching
The expansion is part of a wider move towards community-based NHS care and independent prescribing in pharmacy. Community Pharmacy England says pharmacists will also be able to prescribe within existing Pharmacy First pathways and, in some circumstances, manage prescription issues under agreed arrangements.
For patients, the success of the change will depend on more than the headline. People need to know which pharmacies participate, whether the service is available when they need it, and when pharmacy care is appropriate versus when they should be referred elsewhere.
The bottom line
Pharmacy First is becoming a more substantial route into NHS care. From this autumn, participating pharmacies in England are expected to offer prescribing pathways for migraine, acne, scabies and mild skin infections, acute otitis externa and seasonal allergic rhinitis in children.
The change could make treatment faster and more convenient for many people. But it is not a replacement for clinical judgment or GP and urgent-care services. The safest approach is to use pharmacy for conditions that fit the pathway and to seek further assessment when symptoms are severe, atypical or worsening.
How this could change the first step for common symptoms
For many people, the biggest change is not the medicine itself but the route into care. Someone with a familiar migraine pattern, mild acne or a straightforward seasonal-allergy problem may no longer need to begin by trying to secure a GP appointment. That can be useful when the condition is uncomfortable but not urgent, and when a pharmacist can safely assess whether it fits the national pathway.
The pathway approach is important because it creates boundaries. A pharmacist is not simply prescribing for any person who asks for treatment. The consultation should establish whether the patient falls within the agreed age range, symptom pattern and clinical criteria, and whether there are reasons to refer elsewhere.
What to bring to a pharmacy consultation
A little preparation can make the appointment more useful. Bring or know the names of regular medicines, including inhalers, contraceptives, over-the-counter products and supplements if relevant. Be ready to describe when symptoms began, what makes them better or worse, whether the problem has happened before and what treatments have already been tried.
For children, the pharmacist may need information about age, weight, allergies and other medicines. For adults, pregnancy, breastfeeding, kidney or liver problems and other long-term conditions can affect what treatment is appropriate. Accurate information helps the pharmacist decide whether the pathway is suitable.
Why referral is sometimes the right outcome
A Pharmacy First consultation is still useful even when no medicine is supplied. Referral can be the safest result when symptoms do not fit the expected pattern or when there are warning signs that need another service. That is not a failed consultation; it is part of using community pharmacy as a clinical triage point.
Patients should therefore avoid seeing pharmacy treatment as a guaranteed prescription. The pharmacist’s job is to assess, advise, treat when appropriate and refer when the presentation needs more investigation.
Access, continuity and follow-up
As the service expands, one practical question will be continuity. If treatment is started in a pharmacy and symptoms persist, patients need to know what to do next. Ask how long improvement should take, what side effects to watch for and when a GP or urgent assessment would be appropriate.
It is also sensible to tell your GP about significant new treatment when that information is not automatically visible in the GP record, particularly if you take several medicines or are being monitored for a long-term condition.
What success would look like
The strongest outcome would be a service that makes appropriate care easier to reach without creating confusion about where patients should go. That means enough trained prescribers, clear public information, reliable referral routes and good communication with general practice.
If those pieces work together, Pharmacy First can be more than a convenience scheme. It can become a practical front door for selected common conditions while preserving GP and urgent-care capacity for problems that genuinely need them.
This article provides general information about NHS service changes and does not replace individual medical advice. Service availability may vary by pharmacy and local rollout.
